ENGN FY 2023 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena

ENGNenGene Holdings Inc.

$359M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$175,000

Operating Income

-$26M

Net Income

-$100M

EPS (Diluted)

$-4.24

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$87M

Total Liabilities

$14M

Stockholders' Equity

$72M

Cash & Equivalents

$82M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$175,000	$0	—
Operating Income	-$26M	-$2M	-1322.9%
Net Income	-$100M	$30,726	-325287.1%